美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Prospect Capital Corp

25.06

0.0000

成交量：- -

成交额：31.97万

市值：92.18亿

市盈率：68.17

高：25.06

开：25.06

低：25.06

收：25.06

52周最高：26.49

52周最低：25.00

股本：3.68亿

流通股本：- -

量比：- -

换手率：- -

股息：0.72

股息率：2.87%

每股收益(TTM):0.3676

每股收益(LYR):0.3948

净资产收益率：4.16%

总资产收益率：4.83%

市净率：2.90

市盈率(LYR):63.48

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

原发性胆汁性胆管炎新药在海南博鳌乐城获批

吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批

Tharimmune, Inc.盘中异动早盘股价大涨9.48%报2.54美元

Tharimmune, Inc.盘中异动临近午盘股价大跌6.46%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PBC"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"12-29 16:00:00 EST","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PBC\",,,,,undefined,":{"symbol":"PBC","floatShares":0,"roa":"4.83%","roe":"4.16%","lyrEps":0.394789,"shares":367817926,"dividePrice":0.72,"high":25.06,"amplitude":0,"preClose":25.06,"low":25.06,"week52Low":25,"pbRate":"2.90","week52High":26.49,"institutionHeld":0,"latestPrice":25.06,"eps":0.367626,"divideRate":0.028731,"volume":0,"delay":0,"ttmEps":0.367626,"open":25.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PBC\",params:#limit:5,,,undefined,":[{"date":"2026-02-09","symbol":"PBC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770670800000,"name":null,"time":"盘后","dateTimestamp":1770613200000,"actualEps":null},{"date":"2025-08-26","symbol":"PBC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756238400000,"name":null,"time":"盘后","dateTimestamp":1756180800000,"actualEps":null},{"market":"US","date":"2021-12-30","symbol":"PBC","reason":null,"defaultRemindTime":1640874600000,"announcedDate":"2021-12-01","type":"delisting","dateTimestamp":1640840400000},{"market":"US","date":"2021-11-30","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1638282600000,"name":"Prospect Capital Corp","recordDate":"2021-12-15","payableDate":"2021-12-01","currency":"USD","type":"dividend","dateTimestamp":1638248400000},{"market":"US","date":"2021-08-31","symbol":"PBC","amount":0.4296875,"defaultRemindTime":1630416600000,"name":"Prospect Capital Corp","recordDate":"2021-09-15","payableDate":"2021-09-01","currency":"USD","type":"dividend","dateTimestamp":1630382400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PBC\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":"2019-03-01","paymentDate":"2019-03-15","value":0.4774306,"currency":"USD"},{"executeDate":"2019-08-29","recordDate":"2019-08-30","paymentDate":"2019-09-15","value":0.4296875,"currency":"USD"},{"executeDate":"2019-11-27","recordDate":"2019-11-29","paymentDate":"2019-12-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":"2020-03-15","value":0.4296875,"currency":"USD"},{"executeDate":"2020-05-29","recordDate":"2020-06-01","paymentDate":"2020-06-15","value":0.4296875,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PBC\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593424175","title":"原发性胆汁性胆管炎新药在海南博鳌乐城获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593424175","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593424175?lang=zh_cn&edition=fundamental","pubTime":"2025-12-24 14:53","pubTimestamp":1766559180,"startTime":"0","endTime":"0","summary":"新京报讯 12月22日，原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城国际医疗旅游先行区获批，适用于与熊去氧胆酸联合治疗对UDCA单药应答不佳的PBC成人患者，或作为单药用于治疗无法耐受UDCA的PBC成人患者。该药也是全球首个获批用于治疗原发性胆汁性胆管炎的强效选择性过氧化物酶体增殖物激活受体δ激动剂。原发性胆汁性胆管炎已被纳入我国第二批罕见病目录。谢青表示，Seladelpar以其独特的作用机制为原发性胆汁性胆管炎的治疗带来了突破性变革。","market":"sh","thumbnail":"https://media.bjnews.com.cn/fz/html/AttachPubDev/2025/12/wangl88202512241356572843238.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/fz/html/AttachPubDev/2025/12/wangl88202512241356572843238.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1766559238168453.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1766559238168453.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["PBC"],"gpt_icon":0},{"id":"2593246855","title":"吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593246855","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593246855?lang=zh_cn&edition=fundamental","pubTime":"2025-12-23 10:45","pubTimestamp":1766457935,"startTime":"0","endTime":"0","summary":"【吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批】12月22日，吉利德原发性胆汁性胆管炎(PBC)药物Seladelpar在海南博鳌乐城国际医疗旅游先行区获批，适用于与熊去氧胆酸（UDCA）联合治疗对UDCA单药应答不佳的PBC成人患者，或作为单药用于治疗无法耐受UDCA的PBC成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202512233599290123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"gpt_icon":0},{"id":"2593430618","title":"Tharimmune, Inc.盘中异动 早盘股价大涨9.48%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593430618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593430618?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 22:31","pubTimestamp":1766413907,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分，Tharimmune, Inc.股票出现波动，股价快速拉升9.48%。截至发稿，该股报2.54美元/股，成交量21.4924万股，换手率0.61%，振幅2.15%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"gpt_icon":0},{"id":"2582373562","title":"Tharimmune, Inc.盘中异动 临近午盘股价大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582373562?lang=zh_cn&edition=fundamental","pubTime":"2025-11-12 00:30","pubTimestamp":1762878642,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时30分，Tharimmune, Inc.股票出现异动，股价快速下挫6.46%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PBC\",params:#limit:6,delay:false,,,undefined,":[]}}